Cover Image

Simulants of malignant melanoma

Gérald E. Piérard, Claudine Piérard-Franchimont, Philippe Delvenne
  • Gérald E. Piérard
    Laboratory of Skin Bioengineering and Imaging, Department of Clinical Sciences, Liège University; Department of Dermatopathology, Unilab Lg, Liège University Hospital, Liège, Belgium | gerald.pierard@ulg.ac.be
  • Claudine Piérard-Franchimont
    Laboratory of Skin Bioengineering and Imaging, Department of Clinical Sciences, Liège University, Belgium
  • Philippe Delvenne
    Department of Dermatopathology, Unilab Lg, Liège University Hospital, Liège, Belgium

Abstract

During the recent period, dermoscopy has yielded improvement in the early disclosure of various atypical melanocytic neoplasms (AMN) of the skin. Beyond this clinical procedure, AMN histopathology remains mandatory for establishing their precise diagnosis. Of note, panels of experts in AMN merely report moderate agreement in various puzzling cases. Divergences in opinion and misdiagnosis are likely increased when histopathological criteria are not fine-tuned and when facing a diversity of AMN types. Furthermore, some AMN have been differently named in the literature including atypical Spitz tumor, metastasizing Spitz tumor, borderline and intermediate melanocytic tumor, malignant Spitz nevus, pigmented epithelioid melanocytoma or animal-type melanoma. Some acronyms have been further suggested such as MELTUMP (after melanocytic tumor of uncertain malignant potential) and STUMP (after Spitzoid melanocytic tumor of uncertain malignant potential). In this review, such AMN at the exclusion of cutaneous malignant melanoma (MM) variants, are grouped under the tentative broad heading skin melanocytoma. Such set of AMN frequently follows an indolent course, although they exhibit atypical and sometimes worrisome patterns or cytological atypia. Rare cases of skin melanocytomas progress to loco regional clusters of lesions (agminate melanocytomas), and even to regional lymph nodes. At times, the distinction between a skin melanocytoma and MM remains puzzling. However, multipronged immunohistochemistry and emerging molecular biology help profiling any malignancy risk if present.

Keywords

Melanoma; melanocytoma; prognostic factor; risk stratification; Spitzoid tumor; immunohistochemistry; cell proliferation.

Full Text

PDF
HTML
Submitted: 2015-04-29 08:49:21
Published: 2015-08-05 15:33:56
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
1226

Views:
PDF
470
HTML
640

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2015 Gérald E. Piérard, Claudine Piérard-Franchimont, Philippe Delvenne

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185